These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8423936

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM, Patt YZ, Rosenblum MG, Shanken LJ, Thompson LB, Schweighardt SA, Frincke JM, Murray JL.
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
    Faivre-Chauvet A, Mease RC, Chetanneau A, Bardiès M, Sai-Maurel C, Meinken GE, Srivastava SC, Chatal JF, Gestin JF.
    Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
    [Abstract] [Full Text] [Related]

  • 28. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM, Sharkey RM, Juweid MI, Dunn RM, Ying Z, Zhang CH, Siegel JA, Gold DV, Goldenberg DM.
    Cancer Res; 1996 Apr 15; 56(8):1805-16. PubMed ID: 8620497
    [Abstract] [Full Text] [Related]

  • 29. Comparison of 99Tcm-labelled monoclonal anti-granulocyte antibody and 111In-labelled IgG for the detection of focal sites of infection in rats.
    Juweid M, Fischman AJ, Rubin RH, Baum R, Strauss HW.
    Nucl Med Commun; 1991 Jul 15; 12(7):637-44. PubMed ID: 1923155
    [Abstract] [Full Text] [Related]

  • 30. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
    Buijs WC, Oyen WJ, Dams ET, Boerman OC, Siegel JA, Claessens RA, van der Meer JW, Corstens FH.
    Nucl Med Commun; 1998 Aug 15; 19(8):743-51. PubMed ID: 9751928
    [Abstract] [Full Text] [Related]

  • 31. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
    Riva P, Paganelli G, Callegaro L, Bartoli MG, Turci D, Benini S, Deleide G, Scassellati GA, Viale G, Siccardi AG.
    Nucl Med Commun; 1988 Aug 15; 9(8):577-89. PubMed ID: 3173916
    [Abstract] [Full Text] [Related]

  • 32. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G, Buchegger F, Waibel R, Kuenzi G, Offord RE, Schubiger PA, Gillet M, Delaloye AB.
    Cancer Biother Radiopharm; 2001 Oct 15; 16(5):371-9. PubMed ID: 11776754
    [Abstract] [Full Text] [Related]

  • 33. Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody.
    Aarts F, Boerman OC, Sharkey RM, Hendriks T, Chang CH, McBride WJ, Bleichrodt RP, Oyen WJ, Goldenberg DM.
    Cancer; 2010 Feb 15; 116(4 Suppl):1111-7. PubMed ID: 20127959
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MAb 170H.82: an evaluation of a novel panadenocarcinoma monoclonal antibody labelled with 99Tcm and with 111In.
    McEwan AJ, MacLean GD, Hooper HR, Sykes T, McQuarrie SA, Golberg L, Bodnar DM, Lloyd SL, Noujaim AA.
    Nucl Med Commun; 1992 Jan 15; 13(1):11-9. PubMed ID: 1594163
    [Abstract] [Full Text] [Related]

  • 37. Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients.
    Murray JL, Rosenblum MG, Zhang HZ, Podoloff DA, Kasi LP, Curley SA, Chan JC, Roh M, Hohn DC, Brewer H.
    Cancer; 1994 Feb 01; 73(3 Suppl):850-7. PubMed ID: 8306270
    [Abstract] [Full Text] [Related]

  • 38. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
    Kalofonos HP, Sivolapenko GB, Courtenay-Luck NS, Snook DE, Hooker GR, Winter R, McKenzie CG, Taylor-Papadimitriou JJ, Lavender PJ, Epenetos AA.
    Cancer Res; 1988 Apr 01; 48(7):1977-84. PubMed ID: 2832056
    [Abstract] [Full Text] [Related]

  • 39. Effect of DTPA to antibody ratio on chemical, immunological and biological properties of the 111In-labelled F(ab')2 fragment of the monoclonal antibody 431/31.
    Kuhlmann L, Steinsträsser A.
    Int J Rad Appl Instrum B; 1988 Apr 01; 15(6):617-27. PubMed ID: 3251897
    [Abstract] [Full Text] [Related]

  • 40. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
    Kairemo KJ, Aronen HJ, Liewendahl K, Paavonen T, Heikkonen JJ, Virkkunen P, Mäki-Hokkonen H, Karonen SL, Brownell AL, Mäntylä MJ.
    Acta Oncol; 1993 Apr 01; 32(7-8):771-8. PubMed ID: 8305225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.